Supplementary Table S1 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

Eitemau Tebyg

• Supplementary Table S2 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
  gan: Nan Ding (15321526)
  Cyhoeddwyd: (2025)
• Figure S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
  gan: Yuanqing Ma (15052437)
  Cyhoeddwyd: (2025)
• Figure S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
  gan: Yuanqing Ma (15052437)
  Cyhoeddwyd: (2025)
• Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
  gan: Yuanqing Ma (15052437)
  Cyhoeddwyd: (2025)
• Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
  gan: Yuanqing Ma (15052437)
  Cyhoeddwyd: (2025)